Sysmex Inostics
Papa Kofi F. Baffour-Awuah has a wealth of experience in marketing and brand management, working for various companies in different roles over the years. With a Master of Business Administration degree in Marketing Management/Strategy, Papa Kofi F. has successfully led the development and implementation of marketing campaigns, managed product launches, and worked on special projects to drive business growth. Papa Kofi has also excelled in managing cross-functional teams, analyzing KPI data, and overseeing the budget and P&L of brands. Their expertise in strategic planning, market research, and campaign analysis makes him a valuable asset in the field of marketing.
This person is not in any teams
Sysmex Inostics
Leaders of the Global Liquid Biopsy Revolution As pioneers in blood-based cell-free tumor DNA (ctDNA) mutation detection, Sysmex Inostics has provided custom assays and CLIA-certified lab services to leading BioPharma companies over the last 10 years with the overall goal: to develop therapeutics that extend lives and provide diagnostics to monitor response to therapy, identify targetable resistance alterations, and detect minimal residual disease (MRD). SafeSEQ NGS technology can detect clinically relevant mutations in circulating tumor DNA (ctDNA) with robust detection as low as 0.03% mutant allele frequency (MAF), thus ensuring reliable molecular information for real-time therapy selection as well as monitoring of tumor response from across a broader range of genomic regions.